CompanyGraphWhat stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $8.65M, lower than 95% of all stocks globally
- PositionOperating margin is 59.1%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2025, balance sheet FY2024, cash-flow statement FY2024. Each figure below is labelled with the year it comes from.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
730.35MUSDvs all stocks (USD)
Trailing P/E
105.73xvs Medical Instruments & Supplies peers
Revenue (TTM)
8.65MUSDvs all stocks (USD)
Profit Margin
74.06%vs Medical Instruments & Supplies peers
52-Week Change
3.35%vs all stocks
Market Capitalization
730.35MUSDvs all stocks (USD)
Enterprise Value
696.50MUSDvs all stocks (USD)
Trailing P/E
105.73xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
80.51xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
23.09xvs Medical Instruments & Supplies peers
Enterprise to Revenue
80.55xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
132.06xvs Medical Instruments & Supplies peers
Profit Margin
74.06%vs Medical Instruments & Supplies peers
Operating Margin
59.09%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
14.66%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
27.05%vs Medical Instruments & Supplies peers
Revenue (TTM)
8.65MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.1980USDUpdated Jul 9, 2026Quarterly Revenue Growth
73.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
7.54MUSDvs all stocks (USD)
EBITDA (TTM)
5.27MUSDvs all stocks (USD)
Net Income (TTM)
6.40MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-6.74MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-9.61MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 9, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Revenue
8.65MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.10MUSDFY2025 · Dec 31, 2025Gross Profit
7.54MUSDFY2025 · Dec 31, 2025Operating Income
5.77MUSDvs all stocks (USD)
Pre-tax Income
6.40MUSDFY2025 · Dec 31, 2025Income Tax Expense
0.00USDFY2025 · Dec 31, 2025Net Income
6.40MUSDFY2025 · Dec 31, 2025EBIT
5.77MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
5.27MUSDFY2025 · Dec 31, 2025Research & Development
201.31KUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.57MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
142.02KUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
6.40MUSDFY2025 · Dec 31, 2025Operating Cash Flow
3.93MUSDFY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
11.76MUSDFY2024 · Dec 31, 2024Starting Profit (CF Statement)
2.37MUSDFY2024 · Dec 31, 2024Depreciation & Amortization
0.00USDFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
820.17KUSDFY2024 · Dec 31, 2024Change in Accounts Payable (CF)
798.10KUSDFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
-60.93KUSDFY2024 · Dec 31, 2024Purchase of Investments
-35.47MUSDFY2024 · Dec 31, 2024Sale of Investments
35.80MUSDFY2024 · Dec 31, 2024Net Investing Cash Flow
337.10KUSDFY2024 · Dec 31, 2024Other Financing Charges
-344.61KUSDFY2024 · Dec 31, 2024Net Financing Cash Flow
-344.61KUSDFY2024 · Dec 31, 2024Shares Outstanding
43.89MSharesUpdated Jul 9, 2026Float Shares
39.69MSharesUpdated Jul 9, 2026Shares Short
87.42KSharesUpdated Jul 9, 2026Short Ratio
3.81daysvs all stocks
Short % of Shares Outstanding
0.20%vs all stocks
% Held by Insiders
4.78%vs all stocks
% Held by Institutions
4.90%vs all stocks
Total Cash (MRQ)
11.90MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.2710USDUpdated Jul 9, 2026Total Debt (MRQ)
0.00USDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
344.31xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.6870USDUpdated Jul 9, 2026Total Assets
18.92MUSDvs all stocks (USD)
Total Current Assets
18.53MUSDFY2024 · Dec 31, 2024Total Liabilities
1.73MUSDFY2024 · Dec 31, 2024Total Non-current Assets
387.44KUSDFY2024 · Dec 31, 2024Total Non-current Liabilities
0.00USDFY2024 · Dec 31, 2024Total Current Liabilities
1.73MUSDFY2024 · Dec 31, 2024Cash & Cash Equivalents
11.76MUSDFY2024 · Dec 31, 2024Accounts Receivable
1.06MUSDFY2024 · Dec 31, 2024Accounts Payable
1.63MUSDFY2024 · Dec 31, 2024Common Stock (Book)
14.23KUSDFY2024 · Dec 31, 2024Retained Earnings
17.17MUSDFY2024 · Dec 31, 2024Total Shareholders' Equity
17.19MUSDvs all stocks (USD)
52-Week Low
10.50USDUpdated Jul 9, 202652-Week High
55.65USDUpdated Jul 9, 202652-Week Change
3.35%vs all stocks
50-Day MA
26.51USDUpdated Jul 9, 2026200-Day MA
28.29USDUpdated Jul 9, 2026Avg 10-Day Volume
36.75KSharesUpdated Jul 9, 2026Avg 30-Day Volume
27.86KSharesUpdated Jul 9, 2026Diluted EPS (TTM)
0.1500USDUpdated Jul 9, 2026Other Income / Expense
493.70KUSDFY2025 · Dec 31, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 59.1%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: 0.59Industry median: 0.12Industry P95: 0.27Peers compared: 65.00
Profit margin is 74.1%, higher than 95% of its Medical Instruments & Supplies peers (median 8.2%)Significant
Profit margin: 0.74Industry median: 0.08Industry P95: 0.25Peers compared: 65.00
Return on equity is 27%, higher than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: 0.27Industry median: 0.06Industry P95: 0.21Peers compared: 65.00
Return on assets is 14.7%, higher than 95% of its Medical Instruments & Supplies peers (median 4%)Significant
Return on assets: 0.15Industry median: 0.04Industry P95: 0.13Peers compared: 65.00
Current ratio is 344.31×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 344.311Industry median: 2.21Industry P95: 10.51Peers compared: 65.00
Price-to-book is 23.09×, higher than 95% of its Medical Instruments & Supplies peers (median 2.65×)Significant
Price-to-book: 23.09Industry median: 2.65Industry P95: 9.29Peers compared: 65.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 6,403,463Operating Cash Flow (USD, TTM): -6,739,075
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $8.65M, lower than 95% of all stocks globallySignificant
Revenue (USD): 8,646,844Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Dehong Automotive Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Huatai Paper Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
SJS Enterprises Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Vikram Solar Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wuxi Chemical Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Walton Advanced Engineering Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Sichuan Guoguang Agrochemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Nan Kang Rubber Tire Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Tonglin Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Cayi Vacuum Container Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Great Microwave Technology Co., Ltd.
5 interpretationsMinimal Tax and Interest DragUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedCash Elevated Relative to Current Liabilities and Total AssetsDecline With Range Expansion And DrawdownLiquidity Ratios Elevated
GoldQuest Mining Corp.
4 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedCash Elevated Relative to Current Liabilities and Total AssetsDecline With Range Expansion And DrawdownLiquidity Ratios Elevated
Medlive Technology Co. Ltd.
4 interpretationsMinimal Tax and Interest DragUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios Elevated